Objective: More than 80% of women with breast cancer survive for more than 5 years; quality of life is an important issue in these patients. The aim of this study was to assess differences in quality of life among patients who have undergone breast-conserving surgery, total mastectomy and immediate reconstruction after total mastectomy. Methods: A cross-sectional study was conducted during follow-up visits. Women who underwent surgical treatment at least 2 years prior were eligible if they were aged 20 -70 years and had a diagnosis of breast cancer (Stages 0 -III). Quality of life was evaluated based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire breast cancer-specific module, Rosenberg Self-esteem Scale, Beck Depression Index, Body Image Scale and sexual scale of the Cancer Rehabilitation Evaluation System. Results: A total of 407 patients completed the questionnaires; 254 were treated with breast-conserving surgery, 122 with total mastectomy and 31 with reconstruction after total mastectomy. The mean period between surgery and the survey was 49 months. Women in the breast-conserving surgery group showed better outcomes than women in the total mastectomy and reconstruction after total mastectomy groups with respect to emotional -social function, nausea/vomiting, financial difficulty, body image, arm symptoms and self-esteem. Patients in the reconstruction after total mastectomy group had significantly better outcomes on the sexual scale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire breast cancer-specific module and arm symptoms than the total mastectomy group. Conclusions: Quality of life was better in the breast-conserving surgery group than in the total mastectomy or reconstruction after total mastectomy groups, and the total mastectomy and reconstruction after total mastectomy groups had similar quality of life. Efforts to evaluate and improve the quality of life of patients with breast cancer should be continued.
INTRODUCTION
With the help of increased early detection and improved treatment, up to 89% of patients with breast cancer now survive for 5 years beyond diagnosis (1) . However, patients with breast cancer may be affected psychologically and sexually after undergoing surgery; numerous patients are dissatisfied with their physical appearance and experience a loss of self-confidence (2, 3) . Such findings indicate the importance of maximizing quality of life (QoL) among survivors of breast cancer. Some research indicates that younger women have a poorer QoL following a breast cancer diagnosis and treatment. Moreover, younger patients were more worried about QoL (4, 5) . In Asia, including Korea, the incidence rate among younger patients is high (6) , and therefore a higher level of concern about and evaluation of QoL is necessary.
Various studies have evaluated differences in QoL according to the method of breast cancer surgery. In many cases, breastconserving surgery (BCS) presented the highest rate of satisfaction toward one's physical appearance as well as in sexual life (7 -9) . However, there are also studies in which patients who underwent BCS had no difference in QoL compared with patients who underwent total mastectomy (TM) (10) (11) (12) .
Furthermore, it is unclear whether immediate reconstruction after TM (TM-R) has a positive influence on QoL. In some studies, patients who underwent TM-R had a QoL similar to that of patients who underwent BCS (13, 14) , but investigation of QoL after TM-R is not yet sufficient compared with other surgical methods.
Thus, the aim of this study was to assess differences in QoL according to the surgical techniques used to treat patients with breast cancer.
PATIENTS AND METHODS

STUDY DESIGN AND SUBJECTS
A cross-sectional study design was adopted using selfadministered questionnaires. This study was approved by the institutional review board at our institution and was performed during follow-up clinic visits between October 2011 and May 2012 at Seoul National University Bundang Hospital. Women who underwent surgical treatment for breast cancer at least 2 years prior were eligible to participate in the study if they (1) were between 20 and 70 years of age, (2) had a diagnosis of breast cancer (Stages 0-III), (3) had no evidence of locoregional or systemic recurrences, (4) had no other history of cancer (with the exception of skin or early-stage cervical cancer) and (5) were physically and emotionally able to complete the survey.
The study participants were a convenience sample of all eligible patients during the survey period. Overall, 509 patients were invited to participate in this study by a physician. In total, 407 patients provided their written informed consent and completed the questionnaires, including sociodemographic factors.
INSTRUMENTS
EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is a self-reporting cancer-specific measure of QoL.
It comprises a global health status/QoL scale and five multiitem functional scales that evaluate physical, role, emotional, cognitive and social function. Six single items measure symptoms (dyspnea, insomnia, appetite loss, constipation and diarrhea), and three multi-item symptom scales assess fatigue, pain and nausea/vomiting. Of the 30 items, 28 are scored on four-point Likert scales and the remaining two items for the global health status/QoL scales are scored on seven-point scales. All scales were linearly transformed to a score from 0 to 100, with 100 representing the best global health status/ QoL or functional status, or the worst symptom status (15, 16) . The Korean version of the EORTC QLQ-C30 (version 3.0) was validated in patients with breast cancer (17) . Missing values were handled according to the recommendations in the EORTC QLQ-C30 scoring manual (18) .
EORTC QLQ BREAST CANCER-SPECIFIC MODULE
The EORTC QLQ breast cancer-specific module (EORTC QLQ-BR23) is used to enhance the sensitivity and specificity of the QoL measurement of patients with breast cancer. It is composed of 23 questions assessing functional scales (body image, sexual activity and future perspective) and symptom scales related to treatment (systemic therapy side effects, breast symptoms, arm symptoms and upset by hair loss) (19) . The Korean version of the EORTC QLQ-BR23 has been validated (20) . Scoring and interpreting methods are also included in the EORTC QLQ-C30 scoring manual (16, 18) .
ROSENBERG SELF-ESTEEM SCALE
The Rosenberg Self-esteem Scale (RSES) is designed to assess feelings of self-worth and self-acceptance. Subjects are instructed to rate each item, using a four-point scale ranging from strong agreement to strong disagreement. The total score ranges from 10 to 40, with higher scores indicating higher self-esteem (21) . The Korean version of the RSES has been validated (22) .
BECK DEPRESSION INDEX
Beck Depression Index (BDI) was originally designed to quantify the depth or intensity of depression in psychiatric patients. It evaluates 21 symptoms of depression that represent cognitive-affective content and somatic content. Each symptom is rated on a four-point scale (0 -3) and the scores are added to result in a total ranging from 0 to 63, with higher scores representing more severe depression (23, 24) . The Korean version has been validated (25) .
BODY IMAGE SCALE
The Body Image Scale (BIS) is a 10-item that comprises affective, behavioral and cognitive scale. The 10-item scores are added to produce an overall summary score for each patient, ranging from 0 to 30. Zero represents a good body image, and higher scores represent worsening of body image (26) . Cronbach's a coefficient for all item scales ranged from 0.93 to 0.94 in this study.
CANCER REHABILITATION EVALUATION SYSTEM
The Cancer Rehabilitation Evaluation System (CARES) is a comprehensive survey instrument designed to assess the QoL and rehabilitation needs of cancer survivors. It provides an efficient way of gathering specific information about the day-to-day problems and rehabilitation needs of patients with cancer (27) . The sexual scale of CARES was used to evaluate problems related to interest in and performance of sexual activity. The 12-item scores were summed to produce an overall summary score for each patient, ranging from 12 to 61. A lower score shows less problem on interest and performance of sexual activity. Cronbach's a coefficient for all item scales ranged from 0.87 to 0.89 in this study.
STATISTICAL ANALYSIS
Data were analyzed using SPSS 20.0 for Windows (SPSS, Inc., Chicago, IL, USA). x 2 test was used for comparison of categorical measures, and one-way analysis of variance was used to compare means of continuous measures across three groups. For the analyses that involved adjusting for covariates, analysis of covariance was used. P values ,0.05 were considered statistically significant. All significance tests were two sided. Internal consistency was measured using Cronbach's a coefficient, with a minimum value of 0.70 for retaining items.
RESULTS
A total of 407 women were included in the analysis; 254 (62.4%) underwent BCS, 122 (30%) underwent TM and 31 (7.6%) underwent TM-R. For TM-R, reconstruction using a transverse abdominis myocutaneous flap (n ¼ 25) and a tissue expander followed by an implant (n ¼ 6) was performed. All participants were female, and the mean age was 51.6 years (range, 28 -70 years). The mean period from surgery to the survey was 49 months (range, 24-104 months).
The sociodemographic and clinical characteristics of the surgical treatment groups are summarized in Table 1 . Patients who underwent TM-R were younger than those who underwent BCS or TM (BCS, 52.3 years; TM, 51.9 years; TM-R, 45.2 years; P , 0.001). The mean follow-up period since surgery was longer for patients in the TM-R group than the BCS or TM groups, but there was no statistical difference (BCS, 48.1 months; TM, 49.6 months; TM-R, 56.3 months; P ¼ 0.112). More patients in the TM group had an advanced stage of cancer, whereas most patients in the TM-R group had an early-stage of cancer (P , 0.001). In total, 82.8% of patients in the TM group underwent chemotherapy compared with 48.4% in the TM-R group (P , 0.001). Radiotherapy was performed in 96.1% of patients in the BCS group compared with 16.1% in the TM-R group (P , 0.001). There was no significant difference among the three groups with regard to hormone treatment. There was a statistical difference in monthly income; patients in the TM-R group had the highest monthly income, whereas patients in the TM group had the lowest (P ¼ 0.001). There were no statistical differences with regard to education level, comorbidity and marital status. Table 2 shows the EORTC QLQ-C30 scores adjusted by age, mean follow-up period since surgery, type of axillary operation, stage, chemotherapy, radiotherapy and hormone therapy. With regard to emotional function, patients in the BCS and TM groups had better scores than patients in the TM-R group (BCS, 83.3; TM, 78.1; TM-R, 70.0; P ¼ 0.014). In terms of social function, patients in the BCS group had significantly better scores than patients in the TM and TM-R groups (BCS, 87.9; TM, 81.1; TM-R, 78.0; P ¼ 0.038). With regard to financial difficulty, patients in the TM and TM-R groups had more concerns than patients in the BCS group (BCS, 12.4; TM, 23.0; TM-R, 25.7; P ¼ 0.009). According to the EORTC QLQ-BR23 scores, patients in the BCS group had significantly better results with regard to body image, and no difference between the TM and TM-R groups was found (BCS, 80.6; TM, 54.7; TM-R, 52.9; P , 0.001). Complaining of arm symptoms was higher in the TM group than the BCS and TM-R groups (BCS, 14.9; TM, 25.9; TM-R, 13.9; P , 0.001) ( Table 3) . Table 4 shows the RSES, BDI, BIS and CARES scores by surgical treatment group. Patients in the BCS group reported significantly better self-esteem and body image than patients in the TM and TM-R groups. Based on the sexual scale of CARES, patients in the BCS group had fewer sexual problems than patients in the TM and TM-R groups (P ¼ 0.001). The mean scores for depression among all surgical groups were not statistically different.
DISCUSSION
In this study, various questionnaires were used primarily to detect differences in postoperative patient-reported outcomes among patients who underwent BCS, TM and TM-R. Our results show that the type of primary surgery performed for treatment of patients with breast cancer continues to play an important role in QoL.
Women in the BCS group had better outcomes in emotional and social function, body image, arm symptoms and selfesteem and on the sexual scale of CARES. Superiority of body image is the greatest strength of BCS, and this has been shown in a number of previous studies (7 -9) and again in this study through body image scores on the EORTC QLQ-BR23 and the BIS. Body image is linked closely to identity, selfesteem, attractiveness, sexual functioning and social relationships (28, 29) . Furthermore, psychological distress is associated significantly with poor body image (30) . The role of body image cannot be ruled out when noting that patients in the BCS group had higher scores for emotional -social function and self-esteem and on the sexual scale of CARES in this study. The relevance of body image is even more significant in Asia, including Korea, where the incidence rate among younger patients is high. A better body image cannot induce a general improvement in the QoL of patients with breast
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Compared with other types of surgery, there have not been many studies regarding QoL in patients treated with TM-R. Furthermore, few studies have compared outcomes for women undergoing TM versus TM-R. Several studies have suggested that body image and feelings of attractiveness are improved following immediate reconstruction (31 -33) , although mood state, distress and overall QoL do not differ significantly (34, 35) . In this study, patients in the TM-R and BCS Jpn J Clin Oncol 2014;44(1) 25 groups had better scores with regard to arm symptoms than patients in the TM group. In addition, it is believed to be clinically significant that the average score of the patients in the TM-R group was more than 10 points higher than that of patients in the other groups with regard to the sexual scale of the EORTC QLQ-BR23 (36). However, there was no significant difference between the TM-R and TM groups in general. With regard to financial difficulty, there was no difference in cost between BCS and TM in Korea. However, TM-R costs five to 10 times more than the other types of surgery and is not covered by insurance. As a result, although patients in the TM-R group had the highest income among the three groups, the level of financial difficulty seems to be similar to that of the TM group.
Most QoL studies have been performed with regard to the early postoperative period, which is within ,2 years. Thus, our knowledge regarding the long-term effects of treatment on QoL is limited and timing may be an important factor (7, 10) . The mean period after the surgery in this study was 49 months. In addition, all surgeries except for the reconstruction were performed by one surgeon in this study. This would minimize the potential bias, which could influence various factors of QoL (for example, the surgical technique and patient care after surgery).
This study is a cross-sectional study, and therefore has a limitation in terms of QoL evaluation, despite adjustment for age, clinical stage or treatment factors. In addition, patients with endocrine treatment were included in the study group. The small proportion of patients in the TM-R group (7.6%) was another limiting factor of this study and caused difficulty with regard to analysis. Furthermore, it was inevitable to have missing data to some extent because this is a characteristic trait of self-administered questionnaires. There were no more than two missing data from most of the scales, but 44% of patients did not report sexual enjoyment on the EORTC QLQ-BR23. In total, 43% of patients in the BCS group, 47% in the TM group and 35% in the TM-R group had missing data. In addition, 10% of the patients did not answer more than three of the 12 questions of CARES, and therefore these patients could not be included in the analysis. This study has shown again that BCS results in better QoL or body image, and this can be the foundation for actively advocating BCS among patients with breast cancer. As a part of this effort, active application of neoadjuvant systemic chemotherapy together with a variety of medications should be implemented. Furthermore, regular testing to increase the rate of early detection of breast cancer should be consistently used. In the meantime, for those who have undergone TM, emotional support and management of symptoms will need to be actively provided through consultation, education and rehabilitation.
Our results suggest that breast cancer survivors who underwent BCS exhibited more positive outcomes with respect to emotional -social function, nausea/vomiting, financial difficulty, body image, arm symptoms and self-esteem. Although there were a few differences on some scales, patients who underwent TM or TM-R had a similar QoL. Efforts to evaluate and improve QoL of the patients with breast cancer should be continued.
